These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28234090)

  • 1. Health care burden and medical resource utilisation of idiopathic pulmonary fibrosis in Korea.
    Kim SW; Myong JP; Yoon HK; Koo JW; Kwon SS; Kim YH
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):230-235. PubMed ID: 28234090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
    Raimundo K; Chang E; Broder MS; Alexander K; Zazzali J; Swigris JJ
    BMC Pulm Med; 2016 Jan; 16():2. PubMed ID: 26732054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
    Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
    Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
    Mooney JJ; Raimundo K; Chang E; Broder MS
    J Med Econ; 2017 May; 20(5):518-524. PubMed ID: 28092235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010.
    Navaratnam V; Fogarty AW; Glendening R; McKeever T; Hubbard RB
    Chest; 2013 Apr; 143(4):1078-1084. PubMed ID: 23188187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF; Wu N; Chuang CC; Wang R; Pan X; Benjamin NN; Devercelli G; Coultas DB
    J Manag Care Spec Pharm; 2016 Apr; 22(4):414-23. PubMed ID: 27023695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study).
    Gómez AV; Rodríguez-Nieto MJ; Cano-Jiménez E; Ortiz AR; Morros M; Ramon A; Armengol S
    BMC Pulm Med; 2024 Jul; 24(1):370. PubMed ID: 39080648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the coronavirus disease 2019 pandemic on hospital admissions for idiopathic pulmonary fibrosis: a nationwide population-based study.
    Cho IS; Lim J; Chang MS; Lee JH
    BMC Pulm Med; 2024 Aug; 24(1):430. PubMed ID: 39217306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
    Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
    Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study.
    Cottin V; Schmidt A; Catella L; Porte F; Fernandez-Montoya C; Le Lay K; Bénard S
    PLoS One; 2017; 12(1):e0166462. PubMed ID: 28099456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of illness in idiopathic pulmonary fibrosis.
    Collard HR; Ward AJ; Lanes S; Cortney Hayflinger D; Rosenberg DM; Hunsche E
    J Med Econ; 2012; 15(5):829-35. PubMed ID: 22455577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
    Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
    Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden.
    Mooney JJ; Raimundo K; Chang E; Broder MS
    BMC Pulm Med; 2017 May; 17(1):84. PubMed ID: 28532459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.
    Vaidya S; Hibbert CL; Kinter E; Boes S
    Lung; 2017 Feb; 195(1):1-8. PubMed ID: 27866277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
    Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
    Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
    Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Moodley Y; Goh N; Hopkins P; Macansh S; Walters EH; Palmer AJ
    Eur J Health Econ; 2023 Sep; 24(7):1121-1139. PubMed ID: 36289130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
    Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
    Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.